Exit this survey

31st Annual TNP Conference Session S60 Evaluation - Re-framing the Approach to the Diagnosis and Tre

Speaker: Dan Matthews
Saturday, September 7, 2019

Question Title

* 1. S60: As a result of my participation in Re-framing the Approach to the Diagnosis and Treatment of Borderline Personality Disorder in Adolescents, I am better to:

  Strongly Disagree Disagree Agree Strongly Agree
Demonstrate an understanding of the brain dysfunctions underlying the various symptoms/traits presenting in Borderline Personality Disorder (BPD) as well as the anatomy and physiology.
Identify the neuropharmacological interventions that have been shown to be effective in ameliorating the brain dysfunctions involved in BPD, and their modes of action.
 Describe the target dose and blood level ranges of the anticonvulsant and dopaminergic agonist that have resulted in significant reductions in the symptoms/traits in BPD patients
Develop comfort in the described neuropharmacological protocol in their medical management of BPD patients through Q&A/discussion.

Question Title

* 2. The teaching methods used were appropriate to the objectives.

Question Title

* 3. The presenter demonstrated experiential knowledge of the topic.

Question Title

* 4. The individual objectives/content topic were cohesive with one another.

Question Title

* 5. The content of the program was fair and balanced.

Question Title

* 6. The content of the program was free of commercial bias.

Question Title

* 7. Speaker fully disclosed any conflict of interest and discussion of off-label usage of medication and/or medical devices at beginning of, or during the presentation.

Question Title

* 8. I would recommend this speaker for future conference.

T